Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/644,105external-prioritypatent/US4742004A/en
Application filed by Bio Technology General CorpfiledCriticalBio Technology General Corp
Publication of DD251787A5publicationCriticalpatent/DD251787A5/de
Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda pl promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof
Gewebe-plasminogenaktivator, diesen enthaltende pharmazeutische formulierungen sowie ihre herstellung und ihre verwendung in der human- und veterinaermedizin
Menschliche mangan-superoxiddismutase cdna, ihre expression in bakterien und verfahren zur gewinnung enzymatisch aktiver, menschlicher mangan-superoxiddismutase
Aqueous local anesthetic solution, method for improving solubility of local anesthetic, local anesthetic agent with decreased neurotoxicity and method for decreasing neurotoxicityof local anesthetic agent
Combination of glycoisoforms for the treatment or prevention of septicemia, transgenic cell line that produces erythropoietin glycoisoforms, pharmaceutical composition comprising said combination, method of obtaining the cell line, method of producing the combination of glycoisoforms and methods for the treatment and prevention of septicaemia